{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:08:49Z","timestamp":1791331729124,"version":"4.3.1"},"reference-count":34,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>(1) Background: In this work, we investigated the application of a natural superdisintegrant, psyllium (Plantago ovata Forsk) husk powder, for the manufacture of orodispersible meloxicam tablets. Meloxicam was chosen as a model compound for the study. (2) Methods: The tablets were prepared using different concentrations of psyllium husk by direct compression. Bulk density, tapped density, hardness, friability, in vitro disintegration, and dissolution time tests were used to assess the quality of the formulations. (3) Results: Psyllium husk powder significantly increased the dissolution rate of meloxicam. The formulation containing 16 mg of psyllium husk powder showed the lowest wetting time, the highest water absorption ratio, and the lowest disintegration time compared to the control and to the other formulations. These effects may be attributed to the rapid uptake of water due to the vigorous swelling ability of psyllium husk powder. (4) Conclusions: The powder could be recommended as an effective natural superdisintegrant for orodispersible formulations.<\/jats:p>","DOI":"10.3390\/molecules24183255","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T03:14:41Z","timestamp":1567998881000},"page":"3255","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Psyllium (Plantago Ovata Forsk) Husk Powder as a Natural Superdisintegrant for Orodispersible Formulations: A Study on Meloxicam Tablets"],"prefix":"10.3390","volume":"24","author":[{"given":"Gailute","family":"Draksiene","sequence":"first","affiliation":[{"name":"Department of Drug Technology and Social Pharmacy, Faculty of Pharmacy, Medical Academy, Lithuanian University of Health Sciences, Kaunas 50161, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia M.","family":"Kopustinskiene","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Technologies, Faculty of Pharmacy, Medical Academy, Lithuanian University of Health Sciences, Kaunas 50161, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robertas","family":"Lazauskas","sequence":"additional","affiliation":[{"name":"Institute of Physiology and Pharmacology, Medical Academy, Lithuanian University of Health Sciences, Kaunas 50161, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1744-2932","authenticated-orcid":false,"given":"Jurga","family":"Bernatoniene","sequence":"additional","affiliation":[{"name":"Department of Drug Technology and Social Pharmacy, Faculty of Pharmacy, Medical Academy, Lithuanian University of Health Sciences, Kaunas 50161, Lithuania"},{"name":"Institute of Pharmaceutical Technologies, Faculty of Pharmacy, Medical Academy, Lithuanian University of Health Sciences, Kaunas 50161, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,9,6]]},"reference":[{"key":"ref_1","first-page":"739","article-title":"Plantago ovata: A comprehensive review on cultivation, biochemical, pharmaceutical and pharmacological aspects","volume":"74","author":"Sarfraz","year":"2017","journal-title":"Acta Pol. Pharm."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jep.2005.06.042","article-title":"Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients","volume":"102","author":"Ziai","year":"2005","journal-title":"J. Ethnopharmacol."},{"key":"ref_3","first-page":"137","article-title":"Lowering glycemic index of food by acarbose and Plantago psyllium mucilage","volume":"29","author":"Casarrubias","year":"1998","journal-title":"Arch. Med. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.carbpol.2014.02.022","article-title":"Ispaghula mucilage-gellan mucoadhesive beads of metformin HCl: Development by response surface methodology","volume":"107","author":"Nayak","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Nayak, A.K., Pal, D., and Santra, K. (2013). Plantago ovata F. mucilage-alginate mucoadhesive beads for controlled release of glibenclamide: Development, optimization, and in vitro-in vivo evaluation. J. Pharm., 2013.","DOI":"10.1155\/2013\/151035"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0250-474X.51952","article-title":"Plantago ovata mucilage in the design of fast disintegrating tablets","volume":"71","author":"Shirsand","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1039\/C6FO00785F","article-title":"Sodium ion interaction with psyllium husk (Plantago sp.)","volume":"7","author":"Jimoh","year":"2016","journal-title":"Food Funct."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.carbpol.2018.03.096","article-title":"Rheological and structural properties of complex arabinoxylans from Plantago ovata seed mucilage under non-gelled conditions","volume":"193","author":"Yu","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.carbpol.2017.02.038","article-title":"Multi-layer mucilage of Plantago ovata seeds: Rheological differences arise from variations in arabinoxylan side chains","volume":"165","author":"Yu","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1208\/s12249-007-9026-4","article-title":"Modified polysaccharides as fast disintegrating excipients for orodispersible tablets of roxithromycin","volume":"9","author":"Sharma","year":"2008","journal-title":"Aaps Pharmscitech"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/0976-9668.71663","article-title":"Orodispersible tablets: A new trend in drug delivery","volume":"1","author":"Dey","year":"2010","journal-title":"J. Nat. Sci. Biol. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2478\/v10007-011-0020-8","article-title":"The technologies used for developing orally disintegrating tablets: A review","volume":"61","author":"Badgujar","year":"2011","journal-title":"Acta Pharm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2174\/1567201812666150310151238","article-title":"New generation of orally disintegrating tablets for sustained drug release: A propitious outlook","volume":"12","author":"Elwerfalli","year":"2015","journal-title":"Curr. Drug Deliv."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/0250-474X.180244","article-title":"Oral dispersible system: A new approach in drug delivery system","volume":"78","author":"Hannan","year":"2016","journal-title":"Indian J. Pharm. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.imr.2014.03.002","article-title":"Development and evaluation of orodispersible tablets using a natural polysaccharide isolated from Cassia tora seeds","volume":"3","author":"Pawar","year":"2014","journal-title":"Integr. Med. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejps.2015.02.015","article-title":"Orodispersible drug formulations for children and elderly","volume":"75","author":"Slavkova","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1208\/s12249-016-0558-3","article-title":"Paediatric drug development and formulation design-a European perspective","volume":"18","author":"Kozarewicz","year":"2017","journal-title":"Aaps Pharmscitech"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s12325-010-0073-y","article-title":"Improving medication compliance in patients with depression: Use of orodispersible tablets","volume":"27","author":"Navarro","year":"2010","journal-title":"Adv. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2147\/PPA.S28283","article-title":"A survey of patient preferences for a placebo orodispersible tablet","volume":"6","author":"Wade","year":"2012","journal-title":"Patient Prefer. Adherence"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.drudis.2017.10.003","article-title":"Orodispersible dosage forms: Biopharmaceutical improvements and regulatory requirements","volume":"23","author":"Cilurzo","year":"2018","journal-title":"Drug Discov. Today"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/rheumatology\/35.suppl_1.13","article-title":"A review of the clinical pharmacokinetics of meloxicam","volume":"35","author":"Turck","year":"1996","journal-title":"Rheumatology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/PL00000219","article-title":"Meloxicam oral suspension: A treatment alternative to solid meloxicam formulations","volume":"50","author":"Hanft","year":"2001","journal-title":"Inflamm. Res."},{"key":"ref_24","first-page":"8","article-title":"Formulation and evaluation of meloxicam orally dispersible capsules","volume":"4","author":"Adel","year":"2009","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_25","first-page":"252","article-title":"An overview on superdisintegrants: A review","volume":"4","author":"Irchhiaya","year":"2017","journal-title":"Eur. J. Pharm. Med. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijbiomac.2014.05.019","article-title":"Isolation, characterization and investigation of Plantago ovata husk polysaccharide as superdisintegrant","volume":"69","author":"Pawar","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ejpb.2009.03.005","article-title":"Compaction properties of isomalt","volume":"72","author":"Bolhuis","year":"2009","journal-title":"Eur J. Pharm. Biopharm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/10837450701703147","article-title":"Indentation test for free-flowable powder excipients","volume":"13","author":"Zatloukal","year":"2008","journal-title":"Pharm. Dev. Technol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijpharm.2018.04.058","article-title":"Comparative analyses of flow and compaction properties of diverse mannitol and lactose grades","volume":"546","author":"Paul","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2018.05.061","article-title":"Characterization of mannitol granules and powder: A comparative study using two flowability testers","volume":"547","author":"Takeuchi","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijpharm.2015.08.099","article-title":"Tablets and minitablets prepared from spray-dried SMEDDS containing naproxen","volume":"495","author":"Pobirk","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/jps.20916","article-title":"Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics","volume":"96","author":"Hickey","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"836","DOI":"10.4103\/0250-474X.39448","article-title":"Orodispersible tablets of meloxicam using disintegrant blends for improved efficacy","volume":"69","author":"Swamy","year":"2007","journal-title":"Indian J. Pharm. Sci."},{"key":"ref_34","first-page":"1412","article-title":"Investigations of Plantago ovata husk powder as a disintegrating agent for development of famotidine tablets","volume":"4","author":"Mehta","year":"2011","journal-title":"Int. J. Pharm. Sci. Nanotech."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/18\/3255\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:17:34Z","timestamp":1760188654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/18\/3255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,6]]},"references-count":34,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["molecules24183255"],"URL":"https:\/\/doi.org\/10.3390\/molecules24183255","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,6]]}}}